Samsung BioLogics Co (XKRX:207940) Total Stockholders Equity : ₩10,010,238 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Total Stockholders Equity?

Samsung BioLogics Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩10,010,238 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Samsung BioLogics Co's Book Value per Share for the quarter that ended in Mar. 2024 was ₩140,644.58. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Samsung BioLogics Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.17.

Samsung BioLogics Co Total Stockholders Equity Historical Data

The historical data trend for Samsung BioLogics Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Total Stockholders Equity Chart

Samsung BioLogics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

4,354,453.75

4,598,783.17

4,991,102.14

8,984,474.40

9,830,492.41

Samsung BioLogics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															9,126,412.04	9,311,024.36	9,546,020.29	9,830,492.41	10,010,237.63

Samsung BioLogics Co (XKRX:207940) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Samsung BioLogics Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(10010237.633	-	0)	/	71.174
	=	140,644.58

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Samsung BioLogics Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1442064.646	+	267716.336)	/	10010237.633
	=	0.17

Samsung BioLogics Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Samsung BioLogics Co (XKRX:207940) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

125, Cheomdan-daero, Yeonsu-gu,, Incheon, KOR

Website

https://www.samsungbiologics.com

Samsung BioLogics Co Ltd engaged in development and manufacturing of bio-healthcare products.The Company works namely in Process Development, cGMP Manufacturing, Aseptic Fill and Finish.

Samsung BioLogics Co (XKRX:207940) Headlines

No Headlines